US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

249.65

-16.1400-6.07%

Post-market: 252.002.35+0.94%19:58 EDT

Volume:444.68K

Turnover:115.14M

Market Cap:567.83M

PE:- -

High:271.79

Open:261.76

Low:248.93

Close:265.79

52wk High:341.93

52wk Low:93.20

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.37

T/O Rate:19.55%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Health Care Down on Rotation Out of Defensive Sector

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

Amneal Gets FDA Approval for Generic Hormone Drug

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

Sector Update: Healthcare

MT Newswires Live

Exchange-Traded Funds, US Equities Lower After Midday

MT Newswires Live

GRAIL Risk-Reward Attractive Ahead of FDA Advisory Committee, UBS Says

MT Newswires Live

Worldwide Healthcare Trust Boosts Treasury Stock with Share Buyback

Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)

Sector Update: Healthcare

MT Newswires Live

Personal Group Issues New Shares After PDMR Option Exercise

Xortx Therapeutics announces planned FDA IND submission for XRx-026

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Envista Holdings (NVST) and Inventiva (IVA)

Beta Bionics (BBNX) Faces Securities Lawsuit After 37% Stock Plunge and Alleged Concealment of FDA Safety Warnings

BTIG Remains a Buy on CryoPort (CYRX)

Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB)

AstraZeneca’s BLA for efzimfotase alfa accepted, granted Priority Review by FDA

Simulations Plus Says FDA's Cosmetics Branch Adopts ADMET Predictor

MT Newswires Live

Wall Street Analysts Are Bullish on Top Healthcare Picks

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/LABU/news?page=19"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":249.65,"timestamp":1790884800000,"preClose":265.79,"halted":0,"volume":444675,"hourTrading":{"tag":"盘后","latestPrice":252,"preClose":249.65,"latestTime":"19:58 EDT","volume":3523,"amount":887083.43802,"timestamp":1790899102187,"change":2.35,"changeRate":0.009413,"amplitude":0.011496},"delay":0,"changeRate":-0.060724632228451085,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Post-Mkt","change":-16.14,"latestTime":"10-01 19:58:53 EDT","open":261.76,"high":271.79,"low":248.93,"amount":115144402.4115,"amplitude":0.086008,"askPrice":258,"askSize":200,"bidPrice":251.5,"bidSize":2,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":265.79,"sharesOutstanding":3074486,"nav":260.661,"aum":592869955.42,"dividendRate":0.00362,"bidAskSpread":0.003436,"preHourTrading":{"tag":"盘前","latestPrice":261.6,"preClose":265.79,"latestTime":"09:29 EDT","volume":2318,"amount":612617.1732800001,"timestamp":1790861345993,"change":-4.19,"changeRate":-0.015764,"amplitude":0.02976},"postHourTrading":{"tag":"盘后","latestPrice":252,"preClose":249.65,"latestTime":"19:58 EDT","volume":3523,"amount":887083.43802,"timestamp":1790899102187,"change":2.35,"changeRate":0.009413,"amplitude":0.011496},"volumeRatio":1.368772,"impliedVol":0.9424,"impliedVolPercentile":0.6056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.368772,"shares":2274486,"dividePrice":0.9037,"high":271.79,"amplitude":0.086008,"preClose":265.79,"low":248.93,"week52Low":93.2,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":249.65,"committee":-0.980198,"eps":0,"divideRate":0.00362,"volume":444675,"delay":0,"ttmEps":0,"open":261.76,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":257.32,"twentyDayClose":311.81,"sixtyDayClose":317.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:19,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668897512","title":"Health Care Down on Rotation Out of Defensive Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2668897512","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668897512?lang=en_us&edition=fundamental","pubTime":"2026-09-19 05:31","pubTimestamp":1789767060,"startTime":"0","endTime":"0","summary":"Health-care companies fell as traders rotated out of the defensive sector.Xenon shares tumbled after the drug developer said it was temporarily halting enrollment in a late-stage clinical trial on patients with major depressive disorder and bipolar depression.Novo shares were more or less flat as Canadian regulators approved a generic version of its Ozempic diabetes and weight-loss drug from Swiss pharmaceutical manufacturer Sandoz.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","LABU","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973975","title":"New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973975","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973975?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:32","pubTimestamp":1789763520,"startTime":"0","endTime":"0","summary":"New data revealed that healthcare providers prioritize drowsiness risk, duration of available data demonstrating long-term response and drug-drug interaction profile when selecting a treatment for tar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/18/3364953/0/en/new-teva-study-identifies-the-attributes-that-healthcare-providers-prioritize-when-selecting-a-treatment-for-tardive-dyskinesia-in-older-patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XBI","HCSG","LABU","BK4566","NMS","LU0029874061.USD","BK4137","AIMS","TD","XLV","BK4207","BK4581","BK4585","BK4588","GSIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668735019","title":"Amneal Gets FDA Approval for Generic Hormone Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2668735019","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668735019?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:24","pubTimestamp":1789763040,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals received approval from the Food and Drug Administration for lanreotide, a generic brand of a treatment for hormonal diseases.The product, which will launch immediately, was designated by the FDA as a generic version of Somatuline Depot.Lanreotide was approved as a 120-milligram injection. It is indicated to treat the hormone disorder acromegaly, as well as advanced gastro-enteropancreatic neuroendocrine tumors and carcinoid syndrome.The drug helps control hormone levels and improves progression-free survival in eligible patients with cancer. It also reduces the need for rescue therapy in patients with carcinoid syndrome, which is caused by tumors releasing high amounts of hormones.During the 12 months ended in July, annual sales for Somatuline Depot in the U.S. were $983 million, Amneal said. Somatuline is a registered trademark of the French drug company Ipsen Pharma.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4007","AMRX","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973580","title":"Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973580","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973580?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:05","pubTimestamp":1789761914,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) “announced that the U.S. Food and Drug Administration has approved its lanreotide injection, 120 mg/0.5 mL, in a ster...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-pharmaceuticals-announces-fda-approval-and-launch-of-lanreotide-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-pharmaceuticals-announces-fda-approval-and-launch-of-lanreotide-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","BK4007","LFSC","GNMX","IBB","TECB","PINK","PSCH","XLVX","SYNB","TBXU","BK4585","GDOC","MRNX","FRTY","BMED","NVIB","MRNY","IDNA","IYH","IEIH","MEDI","AMRX","LABU","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668978316","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2668978316","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668978316?lang=en_us&edition=fundamental","pubTime":"2026-09-19 03:38","pubTimestamp":1789760294,"startTime":"0","endTime":"0","summary":"Healthcare stocks were softer late Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each decreasing 0.2%The iShares Biotechnology ETF  fell 1.1%.In corporate news, Eli Lilly  said Friday that the US Food and Drug Administration has approved Inluriyo in combination with Verzenio for breast cancer. Lilly shares were fractionally higher.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PJP","LU2491049909.HKD","LU2028103732.USD","LU0096364046.USD","LU0256863902.USD","LLY","SG9999018857.SGD","SGXZ51526630.SGD","GDOC","SG9999017495.SGD","BK4516","IYH","SGXZ81514606.USD","ELIS","LU1291159041.SGD","WDNA","LU0109394709.USD","LU2746668461.USD","IHE","LU1064131342.USD","LU0158827781.USD","LU0823434583.USD","MEDI","LU2471134879.HKD","LU0353189680.USD","IE0004445239.USD","LU2360106947.USD","LU2265009873.SGD","LU2471134523.USD","LU2552382132.HKD","LU2112291526.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","LU0203201768.USD","SG9999013999.USD","LU0943347566.SGD","BK4599","LU1267930730.SGD","IE00B1BXHZ80.USD","FHLC","LU0097036916.USD","LU1093756168.USD","LU1868837300.USD","LU0316494557.USD","LU2361044949.HKD","LU2237443382.USD","LU1720051017.SGD","LU0210536198.USD","SG9999001176.SGD","LU2896262040.SGD","SG9999015945.SGD","LLYX","LU1061106388.HKD","LU0106261372.USD","LU0234572021.USD","LU2361045086.USD","IE00B775H168.HKD","LLII","LU1551013425.SGD","LU2106854487.HKD","LU2237443895.HKD","LU2023250504.SGD","LU1232071149.USD","CANC","IE0009355771.USD","LU1629891620.HKD","LU1868836757.USD","LU1917777945.USD","LU2237443465.HKD","SG9999001176.USD","OZEM","SG9999014914.USD","LU0683600562.USD","LU0345770308.USD","LU2471134796.USD","LU0094547139.USD","LU2236285917.USD","IE0005OL40V9.USD","LU2468319806.SGD","LU0471298777.SGD","LU1814569148.SGD","LU0417517546.SGD","LU1983299246.USD","IE00B7KXQ091.USD","IE00BK4W5M84.HKD","IE0002141913.USD","LU1868836591.USD","SGXZ57979304.SGD","LU0823434740.USD","AGNG","IE00BN29S564.USD","THNR","BK4534","LU2023250330.USD","GB00BDT5M118.USD","LU0345770993.USD","LU0354030511.USD","LU2237438978.USD","LU2111349929.HKD","LU0708995401.HKD","LU2462591350.SGD","LU2361044865.SGD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU2237443549.SGD","LU2237443978.SGD","LU2324357040.USD","LU2491050154.USD","VHT","LLYZ","LU0203202063.USD","LU0466842654.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU1989771016.USD","LU1280957306.USD","LU0122379950.USD","LU1988902786.USD","SG9999018865.SGD","LU0225283273.USD","IE00B4R5TH58.HKD","LU0323591593.USD","LU0289739699.SGD","LU1623119135.USD","IE00BJJMRX11.SGD","LU2087625088.SGD","LU2108987350.USD","SGXZ31699556.SGD","SGXZ99366536.SGD","TMED","LU0174119429.USD","LU0320765059.SGD","LU0354030438.USD","HRTS","LU1366192091.USD","LU1145028129.USD","LU0889565916.HKD","SG9999014906.USD","LU1551013342.USD","LU2168564065.EUR","LU2213496289.HKD","LU0456855351.SGD","IE00B2B36J28.USD","LU2552382215.SGD","LU2461242641.AUD","LU1057294990.SGD","IE0004445015.USD","XBI","FTXH","LU0882574139.USD","TRUH","LU0256863811.USD","MEDX","LU2491050071.SGD","LU0823416689.USD","CURE","LU0640476718.USD","LU0198837287.USD","LU2750360641.GBP","XLV","IE00BJJMRZ35.SGD","LU0432979614.USD","LU2462157665.USD","IXJ","IE00BKDWB100.SGD","LU1323610961.USD","IE00B4JS1V06.HKD","LU2089284900.SGD","SG9999015978.USD","IE00BFSS7M15.SGD","LU0158827948.USD","JDOC","LU1974910355.USD","LU0820561909.HKD","LU0006306889.USD","LU0079474960.USD","MHIP","LU0320765992.SGD","RXL","SG9999015952.SGD","LU2471134952.CNY","LU0109391861.USD","SG9999014898.SGD","LU1548497426.USD","LU1720051108.HKD","LU2357305700.SGD","IBB","LU2063271972.USD","LU0689472784.USD","LU0353189763.USD","LU1804176565.USD","LU1979441026.SGD","LU2168564222.USD","LU2552382058.USD","IE00BK4W5L77.USD","LU2168564495.EUR","LU2756315318.SGD","LU0786609619.USD","LU0471298694.HKD","LU0964807845.USD","LU0882574055.USD","LU0114720955.EUR","LU2089984988.USD","LU2756315664.SGD","LU0672654240.SGD","SG9999014880.SGD","LU1127390331.HKD","LU2168563687.JPY","LU1712237335.SGD","LU1691799644.USD","LU2264538146.SGD","LU0266013472.USD","BK4581","LU0061475181.USD","LU2237443622.USD","LU2750360997.AUD","PPH","BK4007","LABU","IE00BKPKM429.USD","LU2023251221.USD","LU2417539215.USD","IE00BFTCPJ56.SGD","ELIL","LU0820561818.USD","LU2089283258.USD","LU1093756325.SGD","BK4533","IE00BWXC8680.SGD","LU1023059063.AUD","LU1035775433.USD","LU1868836914.USD","SG9999015986.USD","LU2271345857.HKD","LU2746668974.SGD","LU0385154629.USD","ILDR","LU0058720904.USD","LU0820562030.AUD","LU0133085943.USD","LU0238689110.USD","IE0001KFT4U8.USD","IE00BJLML261.HKD","LU1868837136.USD","LU2168564149.EUR","BK4588","LU2602419157.SGD","LU2456880835.USD","BK4585","LU0787776722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668927144","title":"Exchange-Traded Funds, US Equities Lower After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2668927144","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668927144?lang=en_us&edition=fundamental","pubTime":"2026-09-19 01:18","pubTimestamp":1789751905,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV were lower. Actively traded Invesco QQQ Trust (QQQ) eased 0.1%.US equity indexes fell as government bond yields rebounded, with th","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBOY","NJAN","MAXI","NAPR","QBF","BPI","QDEC","AAAU","DEFI","DGP","SOXL","XLY","XAGUSD.FOREX","BTCW","SHNY","TECL","BITX","BCCC","GLD","SGOL","GLL","BK4547","CBXY","TQQQ","XBI","DULL","BTF","BITU","KGLD","XSD","CBOA","BTC.USD.CC","BAGY","VDC","BGLD","HODL","CBXA","TQQY","BAR","PSQ","QMAR","BETE","BETH","ETCO","CBTY","XRT","NJUL","CBOO","GLDY","CBOJ","XLPU","QQQ","BTCI","ETH","XLK","XLF","XBTY","ARKB","IBIT","GBTC","CBTO","YBTC","ETHT","QQQM","BK4550","NOCT","BITI","IAUI","SQQQ","TETH","BTCZ","BITO","CBTA","DZZ","XLI","QID","BK4504","IYW","BK4585","QQQX","IGM","UCO","AGQ","BK4588","CBXJ","MNRS","BITY","CBXO","FAZ","BRRR","GPIQ","XLPD","ZSL","GCPU","BTCL","XLP","BITB","ESK","XLE","SBIT","SOXS","DGZ","XLV","GLDM","IAU","USG","BTC","IGLD","UGL","IYJ","BK4570","SETH","RTH","SCO","BK4534","FGDL","XAUUSD.FOREX","BTCO","NDX","IAUM","VHT","BK4581","CBTJ","BK4561","IYH","RETL","ETHD","UNG","SLV","EZBC","ETQ","LABU","SOXX","BFAP","BTCC","FBTC","FAS","QLD","IBB","YGLD","ETH.USD.CC","VIS","USO","BK4593","OUNZ","EETH","BFJL","BTRN","IYE","SIVR","DFII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668275329","title":"GRAIL Risk-Reward Attractive Ahead of FDA Advisory Committee, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2668275329","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668275329?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:46","pubTimestamp":1789749962,"startTime":"0","endTime":"0","summary":"GRAIL  has an attractive risk-reward profile ahead of the FDA's Sept. 23 advisory committee meeting on its Galleri multi-cancer detection assay, UBS said in a note.UBS said 225 of 227 public comments submitted to the FDA as of Sept. 15 supported approval, while eight called for stricter labeling, clearer cancer-specific performance disclosures and post-market evidence.The bank expects the FDA briefing documents to provide more clarity on the panel's focus. UBS said the safety profile from the PATHFINDER 2 study provides a strong foundation, while the NHS-Galleri trial's failure to meet its primary endpoint is a notable risk.UBS expects FDA approval next year and said a failure to gain approval could leave the stock trading around $40 to $50 per share, while approval could result in a $150 to $170 per share valuation.UBS reiterated a buy rating and $105 price target.Price: 80.52, Change: +0.57, Percent Change: +0.71","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GRAL","LABU","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668381927","title":"Worldwide Healthcare Trust Boosts Treasury Stock with Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2668381927","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668381927?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:32","pubTimestamp":1789749167,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) has issued an announcement. Worldwide Healthcare Trust PLC, a UK-based investment trust specialisi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-share-buyback-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-share-buyback-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0128526141.USD","BK4588","XLV","LABU","LU0029874061.USD","BK4581","HCSG","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668273689","title":"Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668273689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668273689?lang=en_us&edition=fundamental","pubTime":"2026-09-19 00:30","pubTimestamp":1789749010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Corcept Therapeutics (CORT) and Xenon (XENE) with bu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corcept-therapeutics-cort-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-corcept-therapeutics-cort-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XENE","BK4532","XBI","FBT","BK4139","SBIO","LU0128526141.USD","LU1559883803.SGD","BK4581","BK4137","BK4007","BK4585","LABU","XLV","CORT","PSCH","LU0566484027.USD","LU0029874061.USD","BK4588","HCSG","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668268259","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2668268259","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668268259?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:59","pubTimestamp":1789736375,"startTime":"0","endTime":"0","summary":"Healthcare stocks were flat to lower pre-bell Friday, with the iShares Biotechnology ETF  inactive and the State Street Health Care Select Sector SPDR ETF  down 0.4%.Xenon Pharmaceuticals  shares were down more than 23% after the company voluntarily paused enrollment of new patients in studies for major depressive disorder and bipolar depression.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","LU1883839398.USD","IE00B64PRP62.GBP","HCSG","LU1894683264.USD","BK4137","FDN","BK4135","IE00BGHQF748.EUR","BK4139","BK4588","IBB","XENE","BK4581","XBI","STT","XLV","IE0034235188.USD","IE00B3QW5Z07.USD","SBIO","LU0061475181.USD","BK4585","IBRN","LU0029874061.USD","BK4550","LU0128526141.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668568926","title":"Personal Group Issues New Shares After PDMR Option Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2668568926","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668568926?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:57","pubTimestamp":1789736243,"startTime":"0","endTime":"0","summary":"Personal Group Holdings ( ($GB:PGH) ) has issued an announcement. Personal Group Holdings, a workforce benefits and health insurance specialist hea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/personal-group-issues-new-shares-after-pdmr-option-exercise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/personal-group-issues-new-shares-after-pdmr-option-exercise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4588","BK4585","XBI","LABU","UNHU","UNHW","IYH","UN","BK4581","IHF","UNHG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668923031","title":"Xortx Therapeutics announces planned FDA IND submission for XRx-026","url":"https://stock-news.laohu8.com/highlight/detail?id=2668923031","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668923031?lang=en_us&edition=fundamental","pubTime":"2026-09-18 20:15","pubTimestamp":1789733736,"startTime":"0","endTime":"0","summary":"XORTX Therapeutics (XRTX) outlines its anticipated Investigational New Drug application, IND, submission to the U.S. Food and Drug Administration, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xortx-therapeutics-announces-planned-fda-ind-submission-for-xrx-026-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xortx-therapeutics-announces-planned-fda-ind-submission-for-xrx-026-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4539","LENZ","BK4007","BK4585","BK4139","IND","XRTX","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668282679","title":"Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111","url":"https://stock-news.laohu8.com/highlight/detail?id=2668282679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668282679?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:35","pubTimestamp":1789731320,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics (ABEO) “congratulated” Ultragenyx Pharmaceutical (RARE) on the U.S. Food and Drug Administration, FDA, approval of FAYUVI, also...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-congratulated-ultragenyx-on-u-s-fda-approval-of-ux111-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-congratulated-ultragenyx-on-u-s-fda-approval-of-ux111-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","MRNY","PINK","IYH","RARE","XLVX","SYNB","NVIB","RSPH","ABEO","LFSC","MEDI","GDOC","BK4588","BBP","BMED","GNMX","IBB","IDNA","IEIH","PSCH","FRTY","LABU","TECB","TBXU","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668283929","title":"Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Envista Holdings (NVST) and Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668283929","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668283929?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:10","pubTimestamp":1789729810,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Surgery Partners (SGRY), Envista Holdings (NVST) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-surgery-partners-sgry-envista-holdings-nvst-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-surgery-partners-sgry-envista-holdings-nvst-and-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1201861165.SGD","BK4588","LABU","LU0130103400.USD","SGRY","XBI","XLV","NVST","BK4581","LU0648000940.SGD","BK4139","LU0130518102.USD","IE00B19Z6F94.USD","BK4585","LU0477156797.USD","BK4137","HCSG","BK4185","IE0034390439.USD","LU0128526141.USD","BK4082","LU0029874061.USD","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668401679","title":"Beta Bionics (BBNX) Faces Securities Lawsuit After 37% Stock Plunge and Alleged Concealment of FDA Safety Warnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2668401679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668401679?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:57","pubTimestamp":1789729051,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. ($BBNX) is facing a federal securities lawsuit after investors allege the company hid serious FDA safety concerns about its only...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/beta-bionics-bbnx-faces-securities-lawsuit-after-37-stock-plunge-and-alleged-concealment-of-fda-safety-warnings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/beta-bionics-bbnx-faces-securities-lawsuit-after-37-stock-plunge-and-alleged-concealment-of-fda-safety-warnings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4588","BK4585","LABU","BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668940120","title":"BTIG Remains a Buy on CryoPort (CYRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668940120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668940120?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:55","pubTimestamp":1789728950,"startTime":"0","endTime":"0","summary":"BTIG analyst David Larsen maintained a Buy rating on CryoPort today and set a price target of $25.00. Larsen covers the Healthcare sector, focusing...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-cryoport-cyrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-cryoport-cyrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4602","BK4121","BK4082","BK4588","XBI","XLV","CYRX","BK4581","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668940452","title":"Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668940452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668940452?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:50","pubTimestamp":1789728612,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neuronetics (STIM), Xenon (XENE) and Biogen (BIIB) w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neuronetics-stim-xenon-xene-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neuronetics-stim-xenon-xene-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IE00B19Z9Z06.USD","LABU","XLV","LU0128526141.USD","LU0234570918.USD","BK4585","LU0320765992.SGD","IE00B19Z9P08.USD","BIIB","BK4082","BMED","IE00B894F039.SGD","PBE","SBIO","XENE","HCSG","BK4533","XBI","BK4139","IBRN","LU0889565916.HKD","STIM","LU0029874061.USD","BK4581","BK4532","BK4137","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668705947","title":"AstraZeneca’s BLA for efzimfotase alfa accepted, granted Priority Review by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2668705947","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668705947?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:35","pubTimestamp":1789727735,"startTime":"0","endTime":"0","summary":"Alexion, AstraZeneca’s (AZN) Rare Disease’s Biologics License Application, BLA, for efzimfotase alfa has been accepted and granted Priority Review ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazenecas-bla-for-efzimfotase-alfa-accepted-granted-priority-review-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazenecas-bla-for-efzimfotase-alfa-accepted-granted-priority-review-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443895.HKD","LU0889565916.HKD","LU0708994859.HKD","BK4588","LABU","LU2462157665.USD","BK4568","LU2237443549.SGD","LU2237443978.SGD","LU0310800379.SGD","LU2237443382.USD","LU2237443465.HKD","AZNH","LU1829250122.USD","LU0029864427.USD","LU2237443622.USD","LU0128525929.USD","LU2236285917.USD","LU1267930573.SGD","BK4007","LU2089984988.USD","LU0058720904.USD","LU2456880835.USD","AZN","LU0320765992.SGD","LU2468319806.SGD","IE00B3T34201.USD","LU0289739699.SGD","BK4585","LU0109394709.USD","LU2417539215.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668949108","title":"Simulations Plus Says FDA's Cosmetics Branch Adopts ADMET Predictor","url":"https://stock-news.laohu8.com/highlight/detail?id=2668949108","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668949108?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:43","pubTimestamp":1789721005,"startTime":"0","endTime":"0","summary":"Simulations Plus  said late Thursday the US Food and Drug Administration's cosmetics branch licensed its ADMET Predictor software for use in computational research into modern cosmetic safety assessment.The ADMET Predictor platform provides researchers with predictive modeling driven by advanced artificial intelligence and machine learning technology, the company added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4167","SLP","BK4585","BK4588","QQH","AIQU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668934949","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2668934949","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668934949?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:30","pubTimestamp":1789720218,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Avita Medical (RCEL) and Universal Health (UHS) with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-341?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-341?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4139","RCEL","XBI","XLV","HCSG","UHS","BK4185","BK4585","BK4581","LU0128526141.USD","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":19,"totalSize":387,"code":"91000000","status":"200"}]}}